- You can view the full Biogen Idec Ratings Report.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
While Donald Trump's tweets can shake up pharmaceutical stocks, history suggests that investors have little to fear from the president's drug pricing rhetoric.
Jim Cramer explains how to rely on long-term themes to take advantage of this market's wild action.
Here's what you need to know now for Thursday, Jan. 25